These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28732866)

  • 21. Multi-faceted substrate specificity of heparanase.
    Peterson SB; Liu J
    Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of heparan sulfate: identification of variable and constant oligosaccharide domains in eight heparan sulfates of different origins.
    Dietrich CP; Tersariol IL; Toma L; Moraes CT; Porcionatto MA; Oliveira FW; Nader HB
    Cell Mol Biol (Noisy-le-grand); 1998 May; 44(3):417-29. PubMed ID: 9620437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
    Toma L; Dietrich CP; Nader HB
    Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of the substrate specificity of K5 lyase A from K5A bacteriophage.
    O'Leary TR; Xu Y; Liu J
    Glycobiology; 2013 Jan; 23(1):132-41. PubMed ID: 23019155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The malaria circumsporozoite protein: interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate.
    Ying P; Shakibaei M; Patankar MS; Clavijo P; Beavis RC; Clark GF; Frevert U
    Exp Parasitol; 1997 Feb; 85(2):168-82. PubMed ID: 9030667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous-Flow Accelerated Sulfation of Heparan Sulfate Intermediates.
    Anand S; Mardhekar S; Raigawali R; Mohanta N; Jain P; D Shanthamurthy C; Gnanaprakasam B; Kikkeri R
    Org Lett; 2020 May; 22(9):3402-3406. PubMed ID: 32310663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Research progress of heparinase in the field of medicine].
    Liu W; Jiang Y; Zhao L; Zhang P; Wang S
    Sheng Wu Gong Cheng Xue Bao; 2018 Dec; 34(12):1953-1962. PubMed ID: 30584706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled Chemoenzymatic Synthesis of Heparan Sulfate Oligosaccharides.
    Lu W; Zong C; Chopra P; Pepi LE; Xu Y; Amster IJ; Liu J; Boons GJ
    Angew Chem Int Ed Engl; 2018 May; 57(19):5340-5344. PubMed ID: 29512241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligosaccharide substrate preferences of human extracellular sulfatase Sulf2 using liquid chromatography-mass spectrometry based glycomics approaches.
    Huang Y; Mao Y; Buczek-Thomas JA; Nugent MA; Zaia J
    PLoS One; 2014; 9(8):e105143. PubMed ID: 25127119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluorescent-tagged heparan sulfate precursor oligosaccharides to probe the enzymatic action of heparitinase I.
    Babu P; Kuberan B
    Anal Biochem; 2010 Jan; 396(1):124-32. PubMed ID: 19732739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Facile chemoenzymatic synthesis of unmodified anticoagulant ultra-low molecular weight heparin.
    Zhang G; Yang K; Wang L; Cheng Y; Liu C
    Org Biomol Chem; 2022 Nov; 20(42):8323-8330. PubMed ID: 36239281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatographic identification of eight constitutional disaccharides from heparan sulfate isomers digested with heparitinases.
    Murata K; Murata A; Yoshida K
    J Chromatogr B Biomed Appl; 1995 Aug; 670(1):3-10. PubMed ID: 7493082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Domain structure of endothelial heparan sulphate.
    Lindblom A; Bengtsson-Olivecrona G; Fransson LA
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):821-9. PubMed ID: 1953677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering mode of action of heparanase using structurally defined oligosaccharides.
    Peterson S; Liu J
    J Biol Chem; 2012 Oct; 287(41):34836-43. PubMed ID: 22893710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma.
    Ogren S; Lindahl U
    J Biol Chem; 1975 Apr; 250(7):2690-7. PubMed ID: 804478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides.
    Oldberg A; Heldin CH; Wasteson A; Busch C; Höök M
    Biochemistry; 1980 Dec; 19(25):5755-62. PubMed ID: 7459342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequencing of heparan sulfate proteoglycans: identification of variable and constant oligosaccharide regions in eight heparan sulfate proteoglycans of different origins.
    Tersariol IL; Ferreira TM; Medeiros MG; Porcionatto MA; Moraes CT; Abreu LR; Nader HB; Dietrich CP
    Braz J Med Biol Res; 1994 Sep; 27(9):2097-102. PubMed ID: 7787793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 10E4 antigen of Scrapie lesions contains an unusual nonsulfated heparan motif.
    Leteux C; Chai W; Nagai K; Herbert CG; Lawson AM; Feizi T
    J Biol Chem; 2001 Apr; 276(16):12539-45. PubMed ID: 11278655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei.
    Yu Y; Williams A; Zhang X; Fu L; Xia K; Xu Y; Zhang F; Liu J; Koffas M; Linhardt RJ
    Glycobiology; 2019 Jul; 29(8):572-581. PubMed ID: 31143933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.